OncoMatch/Clinical Trials/NCT05454280
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Is NCT05454280 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies non-drug interventions for surgery.
This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).
Check if I qualifyExtracted eligibility criteria
Disease stage
Required: Stage ANY STAGE
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Fox Chase Cancer Center - Philadelphia · Philadelphia, Pennsylvania
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT05454280 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage ANY STAGE is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify